Document:

Exhibit 10.4.5 Restricted Awards Exec. Officers

[FORM OF
EXECUTIVE OFFICER RESTRICTED STOCK AWARD AGREEMENT]

VENTIV
HEALTH, INC.

RESTRICTED
STOCK AWARD AGREEMENT

THIS
AGREEMENT, dated ________________, is made
between Ventiv Health, Inc., a Delaware corporation (the "Company"), and
___________________________ (the
"Executive").

1.
Restricted
Stock Award. Subject
to the terms and conditions set forth in this Agreement, the Company hereby
grants to the Executive, as of the date hereof (the "Grant Date"), an award of
X,XXX shares
of common stock, par value $.001 per share, of the Company (the "Restricted
Stock"). Subject to the terms of this Agreement, the Executive shall be entitled
to exercise and enjoy all rights and entitlements, and will be subject to all
obligations and restrictions, of ownership of the Restricted Stock as set forth
in the Company's Certificate of Incorporation, as amended. The Restricted Shares
are granted under the Ventiv Health, Inc. 1999 Stock Incentive Plan (the "Plan")
and shall be governed by terms of the Plan, the terms of which are incorporated
by reference into this Restricted Stock Award Agreement.

2.
Restrictions.
The
following restrictions shall apply to each share of Restricted Stock: (i) until
such Restricted Stock vests in accordance with Section 3 hereof, one or more
stock certificates representing the Restricted Stock will be issued in the
Executive's name, but will be held in custody by the Company or an escrow agent
(which may be a brokerage firm) appointed by the Company, and the Executive will
not sell, transfer, assign, give, place in trust, or otherwise dispose of or
pledge, grant a security interest in, or otherwise encumber such unvested
Restricted Stock until the Executive’s interest therein is fully vested, and any
such attempted disposition or encumbrance shall be void and unenforceable
against the Company; (ii) the stock certificate or certificates representing the
Restricted Stock shall initially bear the legends provided for in Sections 7(a)
and 7(b) below; (iii) except as provided in Section 3(b), upon termination of
the Executive's employment with the Company for any reason whatsoever, with or
without cause, whether voluntarily or involuntarily, all shares of Restricted
Stock which had not vested as of the date of such termination will be forfeited
and returned to the Company, and all rights of the Executive or the Executive's
heirs in and to such shares will terminate, unless the Board of Executives of
the Company (the "Board") determines otherwise in its sole and absolute
discretion.

3.
Vesting of Restricted Stock. (a) The Restricted Stock will vest as follows:

	·  	
      XX %
      of such shares of Restricted Stock shall vest on (1st
      anniversary of grant date);

	·  	
      XX %
      of such shares of Restricted Stock shall vest on (2nd
      anniversary of grant date);

	·  	
      XX %
      of such shares of Restricted Stock shall vest on (3rd
      anniversary of grant date);
      and

	·  	
      XX %
      of such shares of Restricted Stock shall vest on
      --------------(4th
      anniversary of grant date).
      

(b) [For
executive officers who are Board members: All unvested shares of Restricted
Stock will immediately become vested in the event that (i) a transaction or a
series of related transactions is consummated involving (A) a sale, transfer or
other disposition of all or substantially all of the Company’s assets, (B) the
consummation of a merger or consolidation of the Company or (C) a sale or
exchange of capital stock of the Company, in any case as a result of which the
stockholders of the Company immediately prior to such transaction or series of
related transactions own, in the aggregate, less than a majority of the
outstanding voting capital stock or equity interests of the surviving, resulting
or transferee entity or (ii) the Executive dies or becomes disabled while the
Executive is employed by the Company.]

[For
other executive officers: All unvested shares of Restricted Stock will
immediately become vested in the event that the Executive’s employment with the
Company is terminated by the Company or its successors or assigns “Without
Cause” (as defined in the Employment Agreement between you and the Company) upon
or before six (6) months following a “Change of Control” (as defined in the
Employment Agreement) of the Company.]

4.
Effect
of Vesting. Subject
to the provisions of this Agreement, upon the vesting of any shares of
Restricted Stock, the Company will deliver to the Executive a certificate or
certificates for the number of shares of Restricted Stock which had so vested,
endorsed with the legend provided for in Section 7(b). Alternatively, the
Company may elect to deliver vested shares of Restricted Stock electronically,
and if it does so, the Executive agrees to establish an account with a brokerage
firm selected by the Company for the purpose of receiving such shares. Subject
to applicable law, the Executive may sell, transfer, assign, give, place in
trust, or otherwise dispose of or pledge, grant a security interest in, or
otherwise encumber vested shares of Restricted Stock. 

5.
Regulatory
Compliance. The
issuance and delivery of any stock certificates representing vested shares of
Restricted Stock may be postponed by the Company for such period as may be
required to comply with any applicable requirements under the federal securities
laws or under any other law or regulation applicable to the issuance or delivery
of such shares. The Company shall not be obligated to deliver any vested shares
of Restricted Stock to the Executive if the Company believes that such delivery
would constitute a violation of any applicable law or regulation.

6.
Representations
and Warranties. The
Executive hereby represents and warrants that the Restricted Stock awarded
pursuant to this Agreement is being acquired for the Executive's own account,
for investment purposes and not with a view to distribution thereof. The
Executive acknowledges and agrees that any sale or distribution of shares of
Restricted Stock that have become vested may be made only pursuant to either (i)
a registration statement on an appropriate form under the Securities Act of
1933, as amended (the "Securities Act"), which registration statement has become
effective and is current with regard to the shares being sold, or (ii) a
specific exemption from the registration requirements of the Securities Act that
is confirmed in a favorable written opinion of counsel, in form and substance
satisfactory to counsel for the Company, prior to any such sale or distribution.
The Executive hereby consents to such action as the Board or the Company deems
necessary or appropriate from time to time to prevent a violation of, or to
perfect an exemption from, the registration requirements of the Securities Act
or to implement the provisions of this Agreement, including but not limited to
placing restrictive legends on certificates evidencing shares of Restricted
Stock (whether or not vested) and delivering stop transfer instructions to the
Company's stock transfer agent.

7.
Legends.
(a) Each
certificate representing any unvested shares of Restricted Stock shall be
endorsed with a legend in substantially the following form:

"THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A CERTAIN RESTRICTED
STOCK AWARD AGREEMENT, DATED AS OF (GRANT
DATE), WHICH
PROVIDES, AMONG OTHER THINGS, FOR CERTAIN RESTRICTIONS ON THE TRANSFER AND
ENCUMBRANCE OF SUCH SHARES. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL
OFFICES OF THE COMPANY"

(b) In
addition to the legend set forth in paragraph (a) and above, until registered
under the Securities Act, each certificate representing shares of Restricted
Stock shall be endorsed with a legend in substantially the following
form:

"THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. SUCH
SECURITIES MAY NOT BE SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
WITHOUT SUCH REGISTRATION, EXCEPT UPON DELIVERY TO THE COMPANY OF SUCH EVIDENCE
AS MAYBE SATISFACTORY TO COUNSEL FOR THE COMPANY TO THE EFFECT THAT ANY SUCH
TRANSFER SHALL NOT BE IN VIOLATION OF THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS OR ANY RULE OR REGULATION PROMULGATED
THEREUNDER";

8.
Miscellaneous

(a)
Construction. This
Agreement will be construed by and administered under the supervision of the
Board, and all determinations of the Board will be final and binding on the
Executive.

(b)
Dilution. Nothing
in this Agreement will restrict or limit in any way the right of the Board to
issue or sell stock of the Company (or securities convertible into stock of the
Company) on such terms and conditions as it deems to be in the best interests of
the Company, including, without limitation, stock and securities issued or sold
in connection with mergers and acquisitions, stock and securities issued or sold
in connection with investments in the Company, stock issued or sold in
connection with any stock option or similar plan, and stock issued or
contributed to any qualified stock bonus or employee stock ownership
plan.

(c)
Notices. Any
notice hereunder shall be in writing and personally delivered or sent by
registered or certified mail, return receipt requested, and addressed to the
Company at Ventiv Health, Inc., 200 Cottontail Lane, Vantage Court North,
Somerset, New Jersey 08873, Attention: Chief Financial Officer, or to the
Executive at 200 Cottontail Lane, Vantage Court North, Somerset, New Jersey
08873, subject to the right of any party hereto to designate at any time
hereafter in writing some other address.

(d)
Counterparts. This
Agreement may be executed in counterparts each of which taken together shall
constitute one and the same instrument.

(e)
Governing
Law. This
Agreement, which constitutes the entire agreement of the parties with respect to
the grant to the Executive of the Restricted Stock, shall be governed by, and
construed and enforced in accordance with, the laws of the State of New York,
without regard to principles thereof regarding conflict of laws.

(f)
Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be prohibited by or invalid under applicable law,
such provision shall be ineffective only to the extent of such prohibition or
invalidity, without invalidating the remainder of this Agreement.

(g)
Amendment
and Waiver. The
provisions of this Agreement may be amended and waived only with the prior
written consent of the Company and the Executive.

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year
first above written.

VENTIV
HEALTH, INC.

By:
___________________________________

Name:

Title:

____________________________________

ExecutiveEXHIBIT 10.1

 

THIS WARRANT AND THE
SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE LAWS, AND NO
INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR
OTHERWISE TRANSFERRED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER
SUCH ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION OR
SUCH TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND
LAWS, SUCH COMPLIANCE, AT THE OPTION OF THE CORPORATION, TO BE EVIDENCED BY AN
OPINION OF WARRANTHOLDER’S COUNSEL, IN FORM ACCEPTABLE TO THE CORPORATION,
THAT NO VIOLATION OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM ANY
PROPOSED TRANSFER OR ASSIGNMENT.

 

 

SERIES “DD-1”
COMMON STOCK PURCHASE WARRANT

 

Bioject
Medical Technologies Inc.

 

 

THIS CERTIFIES that for
good and valuable consideration received, Maxim Group, or registered assigns,
is entitled, upon the terms and subject to the conditions hereinafter set
forth, to acquire from Bioject Medical Technologies Inc., an Oregon corporation
(the “Corporation”) up to 100,000 fully paid and nonassessable shares of common
stock, without par value, of the Corporation (“Warrant Stock”) at a purchase
price per share (the “Exercise Price”) of $1.92.

 

1.                                      Term
of Warrant

 

Subject to the terms and
conditions set forth herein, this Warrant shall be exercisable, in whole or
from time to time part, at any time on or after the date hereof and at or prior
to 11:59 p.m., Pacific Standard Time, on June 19, 2010 (the “Expiration
Time”).

 

2.                                      Exercise
of Warrant

 

The purchase rights
represented by this Warrant are exercisable by the registered holder hereof, in
whole or in part, at any time and from time to time at or prior to the
Expiration Time by the surrender of this Warrant and the Notice of Exercise
form attached hereto duly executed to the office of the Corporation at
Bedminster Professional Center, 211 Somerville Road (Route 202 North),
Bedminster, NJ 07921 (or such other office or agency of the Corporation as it
may designate by notice in writing to the registered holder hereof at the
address of such holder appearing on the books of the Corporation), and upon
payment of the Exercise Price for the shares thereby purchased (by cash or by
check or bank draft payable to the order of the Corporation or by cancellation
of indebtedness of the Corporation to the holder hereof, if any, at the time of
exercise in an amount equal to the purchase price of the shares thereby
purchased); whereupon the holder of this Warrant shall be entitled to receive
from the Corporation a stock certificate in proper form representing the number
of shares of Warrant Stock so purchased.

 

3.                                      Issuance
of Shares; No Fractional Shares of Scrip

 

Certificates for shares
purchased hereunder shall be delivered to the holder hereof by the Corporation’s
transfer agent at the Corporation’s expense within a reasonable time after the
date on which this Warrant shall have been exercised in accordance with the
terms hereof.  Each certificate so
delivered shall be in such denominations as may be requested by the holder
hereof and shall be registered in the name of such holder or, subject to
applicable laws, other name as shall be requested by such holder.  If, upon exercise of this Warrant, fewer than
all of the shares of Warrant Stock evidenced by this Warrant are purchased
prior to the Expiration Time, one or more new warrants substantially in the
form of, and on the terms in, this Warrant will be issued for the remaining
number of shares of Warrant Stock not purchased upon exercise of this
Warrant.  The Corporation hereby
represents and warrants that all shares of Warrant Stock which may be issued
upon the exercise of this Warrant will, upon such exercise, be duly and validly
authorized and issued, fully paid and nonassessable and free from all taxes,
liens and charges in respect of the

 

1

 

issuance
thereof (other than liens or charges created by or imposed upon the holder of
the Warrant Stock).  The Corporation
agrees that the shares so issued shall be and be deemed to be issued to such
holder as the record owner of such shares as of the close of business on the
date on which this Warrant shall have been surrendered for exercise in
accordance with the terms hereof.  No
fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant.  With
respect to any fraction of a share called for upon the exercise of this
Warrant, an amount equal to such fraction multiplied by the then current price
at which each share may be purchased hereunder shall be paid in cash to the
holder of this Warrant.

 

4.                                      Charges,
Taxes and Expenses

 

Issuance of certificates
for shares of Warrant Stock upon the exercise of this Warrant shall be made
without charge to the holder hereof for any issue or transfer tax or other
incidental expense in respect of the issuance of such certificate, all of which
taxes and expenses shall be paid by the Corporation, and such certificates
shall be issued in the name of the holder of this Warrant or in such name or
names as may be directed by the holder of this Warrant; provided, however,
that in the event certificates for shares of Warrant Stock are to be issued in
a name other than the name of the holder of this Warrant, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached
hereto duly executed by the holder hereof.

 

5.                                      No
Rights as Shareholders

 

This Warrant does not
entitle the holder hereof to any voting rights or other rights as a shareholder
of the Corporation prior to the exercise hereof.

 

6.                                      Exchange
and Registry of Warrant

 

This Warrant is
exchangeable, upon the surrender hereof by the registered holder at the
above-mentioned office or agency of the Corporation, for a new Warrant of like
tenor and dated as of such exchange.  The
Corporation shall maintain at the above-mentioned office or agency a registry
showing the name and address of the registered holder of this Warrant.  This Warrant may be surrendered for exchange,
transfer or exercise, in accordance with its terms, at such office or agency of
the Corporation, and the Corporation shall be entitled to rely in all respects,
prior to written notice to the contrary, upon such registry.

 

7.                                      Loss,
Theft, Destruction or Mutilation of Warrant

 

Upon receipt by the
Corporation of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant, and in case of loss, theft or
destruction of indemnity or security reasonably satisfactory to it, and upon
reimbursement to the Corporation of all reasonable expenses incidental thereto,
and upon surrender and cancellation of this Warrant, if mutilated, the
Corporation will make and deliver a new Warrant of like tenor and dated as of such
cancellation, in lieu of this Warrant.

 

8.                                      Saturdays,
Sundays and Holidays

 

If the last or appointed
day for the taking of any action or the expiration of any right required or
granted herein shall be a Saturday or a Sunday or shall be a legal holiday,
then such action may be taken or such right may be exercised on the next
succeeding day not a Saturday, Sunday or legal holiday.

 

2

 

9.                                      Merger,
Sale of Assets, Etc.

 

If at any time the
Corporation proposes to merge or consolidate with or into any other
corporation, effect any reorganization, or sell or convey all or substantially
all of its assets to any other entity, then, as a condition of such
reorganization, consolidation, merger, sale or conveyance, the Corporation or
its successor, as the case may be, shall enter into a supplemental agreement to
make lawful and adequate provision whereby the holder shall have the right to
receive, upon exercise of the Warrant, the kind and amount of equity securities
which would have been received upon such reorganization, consolidation, merger,
sale or conveyance by a holder of a number of shares of common stock equal to
the number of shares issuable upon exercise of the Warrant immediately prior to
such reorganization, consolidation, merger, sale or conveyance.  If the property to be received upon such
reorganization, consolidation, merger, sale or conveyance is not equity
securities, the Corporation shall give the holder of this Warrant ten (10) business
days prior written notice of the proposed effective date of such transaction,
and if this Warrant has not been exercised by or on the effective date of such
transaction, it shall terminate.

 

10.                               Subdivision, Combination,
Reclassification, Conversion, Etc.

 

If the Corporation at any
time shall, by subdivision, combination, reclassification of securities or
otherwise, change the Warrant Stock into the same or a different number of
securities of any class or classes, this Warrant shall thereafter entitle the
holder to acquire such number and kind of securities as would have been
issuable in respect of the Warrant Stock (or other securities which were
subject to the purchase rights under this Warrant immediately prior to such
subdivision, combination, reclassification or other change) as the result of
such change if this Warrant had been exercised in full for cash immediately
prior to such change.  The Exercise Price
hereunder shall be adjusted if and to the extent necessary to reflect such
change.  If the Warrant Stock or other
securities issuable upon exercise hereof are subdivided or combined into a
greater or smaller number of shares of such security, the number of shares
issuable hereunder shall be proportionately increased or decreased, as the case
may be, and the Exercise Price shall be proportionately reduced or increased,
as the case may be, in both cases according to the ratio which the total number
of shares of such security to be outstanding immediately after such even bears
to the total number of shares of such security outstanding immediately prior to
such event.  The Corporation shall give
the holder prompt written notice of any change in the type of securities
issuable hereunder, any adjustment of the Exercise Price for the securities
issuable hereunder, and any increase or decrease in the number of shares
issuable hereunder.

 

11.                               Transferability;
Compliance with Securities Laws

 

(a)                                  This
Warrant may not be transferred or assigned in whole or in part without
compliance with all applicable federal and state securities laws by the
transferor and transferee (including the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Corporation, if
requested by the Corporation). Subject such restrictions, prior to the
Expiration Time, this Warrant and all rights hereunder are transferable by the
holder hereof, in whole or in part, at the office or agency of the Corporation
referred to in Section 1 hereof. 
Any such transfer shall be made in person or by the holder’s duly
authorized attorney, upon surrender of this Warrant together with the
Assignment Form attached hereto properly endorsed.

 

(b)                                 The
Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant
and the Warrant Stock issuable upon exercise hereof are being acquired solely
for the holder’s own account and not as a nominee for any other party, and for
investment, and that the holder will not offer, sell or otherwise dispose of
this Warrant or any shares of Warrant Stock to be issued upon exercise hereof
except under circumstances that will not result in a violation of the
Securities Act of 1933, as amended, or any state securities laws.  Upon exercise of this Warrant, the holder
shall, if requested by the Corporation, confirm in writing, in a form
satisfactory to the Corporation, that the shares of Warrant Stock so purchased
are being acquired solely for holder’s own account and not as a nominee for any
other party, for investment, and not with a view toward distribution or resale.

 

(c)                                  The
Warrant Stock has not been and will not be registered under the Securities Act
of 1933, as amended, and this Warrant may not be exercised except by an “accredited
investor” as defined in Rule 501(a) under the Securities Act of 1933,
as amended. Each certificate representing the Warrant Stock or other securities
issued in respect of the Warrant Stock upon any stock split, stock dividend,
recapitalization, merger, consolidation or similar event, shall be stamped or
otherwise imprinted with a legend substantially in the following form (in
addition to any legend required under applicable securities laws):

 

3

 

THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER UNITED STATES FEDERAL OR
STATE SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE
TRANSFERRED OR ASSIGNED FOR VALUE, DIRECTLY OR INDIRECTLY, NOR MAY THE
SECURITIES BE TRANSFERRED ON THE BOOKS OF THE CORPORATION, WITHOUT REGISTRATION
OF SUCH SECURITIES UNDER ALL APPLICABLE UNITED STATES FEDERAL OR STATE SECURITIES
LAWS OR COMPLIANCE WITH AN APPLICABLE EXEMPTION THEREFROM, SUCH COMPLIANCE, AT
THE OPTION OF THE CORPORATION, TO BE EVIDENCED BY AN OPINION OF SHAREHOLDER’S
COUNSEL, IN FORM ACCEPTABLE TO THE CORPORATION, THAT NO VIOLATION OF SUCH
REGISTRATION PROVISIONS WOULD RESULT FROM ANY PROPOSED TRANSFER OR ASSIGNMENT.

 

12.                               Representations
and Warranties

 

The Corporation hereby
represents and warrants to the holder hereof that:

 

(a)                                  during the period this Warrant is outstanding, the
Corporation will reserve from its authorized and unissued common stock a
sufficient number of shares to provide for the issuance of Warrant Stock upon
the exercise of this Warrant;

 

(b)                                 the
issuance of this Warrant shall constitute full authority to the Corporation’s
officers who are charged with the duty of executing stock certificates to
execute and issue the necessary certificates for the shares of Warrant Stock
issuable upon exercise of this Warrant;

 

(c)                                  the
Corporation has all requisite legal and corporate power to execute and deliver
this Warrant, to sell and issue the Warrant Stock hereunder, to issue the
common stock issuable upon exercise of the Warrant Stock and to carry out and
perform its obligations under the terms of this Warrant;

 

(d)                                 all
corporate action on the part of the Corporation, its directors and shareholders
necessary for the authorization, execution, delivery and performance of this
Warrant by the Corporation, the authorization, sale, issuance and delivery of
the Warrant Stock and the performance of the Corporation’s obligations
hereunder has been taken;

 

(e)                                  the
Warrant Stock, when issued in compliance with the provisions of this Warrant
and the Corporation’s Articles of Incorporation (as they may be amended from
time to time (the “Articles”)), will be validly issued, fully paid and
nonassessable, and free of all taxes, liens or encumbrances with respect to the
issue thereof, and will be issued in compliance with all applicable federal and
state securities laws; and

 

(f)                                    the issuance of the Warrant Stock will not be subject to any
preemptive rights, rights of first refusal or similar rights.

 

13.                               Corporation

 

The Corporation will not,
by amendment of its Articles or through any reorganization, recapitalization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other action, avoid or seek to avoid the observance or
performance of any of the terms to be observed or performed hereunder by the
Corporation, but will at all times in good faith assist in the carrying out of
all the provisions of this Warrant and in the taking of all such action as may
be necessary or appropriate in order to protect the rights of the holder of the
Warrant against impairment.

 

4

 

14.                               Governing
Law

 

This Warrant shall be
governed by and construed in accordance with the laws of the State of Oregon.

 

 

IN WITNESS WHEREOF, the
Corporation has caused this Warrant to be executed by its duly authorized
officers.

 

	
  Dated: June 20,
  2005

  
	
   

  
	
   

  
	
  BIOJECT MEDICAL TECHNOLOGIES
  INC.

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
  Name: Christine M.
  Farrell

  
	
  Title: Controller &
  Secretary

  

 

5

 

NOTICE OF
EXERCISE

 

To:                              Bioject
Medical Technologies Inc.

 

(1)                                  The undersigned hereby elects to purchase                 
shares of common stock of Bioject Medical Technologies Inc. pursuant to the
terms of the attached Warrant, and tenders herewith payment of the purchase
price in full, together with all applicable transfer taxes, if any.

 

(2)                                  In
exercising this Warrant, the undersigned hereby confirms and acknowledges that
the shares of common stock to be issued upon exercise hereof are being acquired
solely for the account of the undersigned and not as a nominee for any other
party, and for investment, and that the undersigned will not offer, sell or
otherwise dispose of any such shares of common stock except under circumstances
that will not result in a violation of the Securities Act of 1933, as amended,
or any state securities laws.

 

(3)                                  Please
issue a certificate or certificates representing said shares of common stock in
the name of the undersigned or in such other name as is specified below:

 

 

	
   

  	
   

  	
   

  
	
   

  	
  (Name)

  	
   

  
	
   

  
	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  (Address)

  	
   

  

 

(3)                                  The
undersigned represents that (a) he, she or it is an “accredited investor”
within the meaning of Rule 501(a) under the Securities Act of 1933,
as amended and (b) the aforesaid shares of common stock are being acquired
for the account of the undersigned for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the
undersigned has no present intention of distributing or reselling such shares.

 

 

	
   

  	
   

  	
   

  
	
  (Date)

  	
   

  	
  (Signature)

  

 

6

 

ASSIGNMENT
FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)

 

 

FOR VALUE RECEIVED, the
undersigned registered owner of this Warrant hereby sells, assigns and
transfers unto the Assignee named below all of the rights of the undersigned
under the within Warrant, with respect to the number of shares of common stock
of Bioject Medical Technologies Inc. set forth below:

 

	
  Name of Assignee

  	
   

  	
  Address

  	
   

  	
  No. of Shares

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

and
does hereby irrevocably constitute and appoint Attorney                                    
to make such transfer on the books of Bioject Medical Technologies Inc.,
maintained for the purpose, with full power of substitution in the premises.

 

The undersigned also
represents that, by assignment hereof, the Assignee acknowledges that this
Warrant and the shares of stock to be issued upon exercise hereof are being
acquired for investment and that the Assignee will not offer, sell or otherwise
dispose of this Warrant or any shares of stock to be issued upon exercise
hereof except under circumstances which will not result in a violation of the
Securities Act of 1933, as amended, or any state securities laws.  Further, the Assignee shall, if requested by
the Corporation, confirm in writing, in a form satisfactory to the Corporation,
that the shares of stock so purchased are being acquired for investment and not
with a view toward distribution or resale.

 

 

	
   

  	
  Dated:

  	
   

  
	
   

  	
   

  
	
   

  	
  Holder’s Signature:

  	
   

  
	
   

  	
   

  
	
   

  	
  Holder’s Address:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
				

 

 

Guaranteed Signature:

 

NOTE:  The signature to this Assignment Form must
correspond with the name as it appears on the face of the Warrant, without
alteration or enlargement or any change whatever, and must be guaranteed by a
bank or trust company.  Officers of
corporations and those action in a fiduciary or other
representative capacity should file proper evidence of authority to assign the
foregoing Warrant.

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]